detailed description | ICD-O3 code |
Myeloproliferative neoplasms | |
Chronic myelogenous leukaemia, BCR-ABL1 positive | 9975/3 |
Chronic neutrophilic leukaemia | 9963/3 |
Polycythaemia vera | 9950/3 |
Primary myelofibrosis | 9961/3 |
Essential thrombocythaemia | 9962/3 |
Chronic eosinophilic leukaemia, NOS | 9964/3 |
Cutaneous mastocytosis | 9740/3 |
Systemic mastocytosis | 9741/3 |
Mast cell leukaemia | 9742/3 |
Mast cell sarcoma | 9740/3 |
Extracutaneous mastocytoma | 9740/1 |
Myeloproliferative neoplasm, unclassifiable | 9975/3 |
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 | |
Myeloid and lymphoid neoplasms with PDGFRA rearrangement | 9965/3 |
Myeloid and lymphoid neoplasms with PDGFRB rearrangement | 9966/3 |
Myeloid and lymphoid neoplasms with FGFR1 rearrangement | 9967/3 |
Myelodysplastic/myeloproliferative neoplasms | |
Chronic myelomonocytic leukaemia | 9945/3 |
Atypical chronic myeloid leukaemia, BCR-ABL1 negative | 9876/3 |
Juvenile myelomonocytic leukaemia | 9946/3 |
Myelodysplastic/myeloproliferative neoplasm, unclassifiable | 9975/3 |
Refractory anemia with ring sideroblasts associated with marked thrombocytosis | 9982/3 |
Myelodysplastic syndromes | |
Refractory anemia | 9980/3 |
Refractory neutropenia | 9991/3 |
Refractory thrombocytopemia | 9992/3 |
Refractory anaemia with ring sideroblasts | 9982/3 |
Refractory cytopenia with multilineage dysplasia | 9985/3 |
Refractory anaemia with excess blasts | 9983/3 |
Myelodysplastic syndrome with isolated del(5q) | 9986/3 |
Myelodysplastic syndrome, unclassifiable | 9989/3 |
Childhood myelodysplastic syndrome | NS |
Refractory cytopenia of childhood | 9985/3 |
Acute myeloid leukaemia (AML) and related precursor neoplasms | |
AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 | 9896/3 |
AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | 9871/3 |
Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA | 9866/3 |
AML with t(9;11)(p22;q23); MLLT3-MLL | 9897/3 |
AML with t(6;9)(p23;q34); DEK-NUP214v | 9865/3 |
AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1 | 9869/3 |
AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1 | 9911/3 |
AML with mutated NPM1 | 9861/3 |
AML with mutated CEBPA | 9861/3 |
AML with myelodysplasia-related changes | 9895/3 |
Therapy-related myeloid neoplasms | 9920/3 |
Acute myeloid leukaemia, NOS | 9861/3 |
AML with minimal differentiation | 9872/3 |
AML without maturation | 9873/3 |
AML with maturation | 9874/3 |
Acute myelomonocytic leukaemia | 9867/3 |
Acute monoblastic and monocytic leukaemia | 9891/3 |
Acute erythroid leukaemia | 9840/3 |
Acute megakaryoblastic leukaemia | 9910/3 |
Acute basophilic leukaemia | 9870/3 |
Acute panmyelosis with myelofibrosis | 9931/3 |
Myeloid sarcoma | 9872/3 |
Transient abnormal myelopoiesis | 9898/1 |
Myeloid leukaemia associated with Down syndrome | 9898/3 |
Blastic plasmacytoid dendritic cell neoplasm | 9727/3 |
Acute leukaemias of ambiguous lineage | |
Acute undifferentiated leukaemia | 9801/3 |
Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 | 9806/3 |
Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged | 9807/3 |
Mixed phenotype acute leukaemia, B/myeloid, NOS 152 | 9808/3 |
Mixed phenotype acute leukaemia, T/myeloid, NOS 153 | 9809/3 |
Mixed phenotype acute leukaemia, NOS - rare types | NS |
Other ambiguous lineage leukaemias | NS |
Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma | NS |